Your browser doesn't support javascript.
loading
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors.
Shaikh, Raja; Weil, Brent R; Weldon, Christopher B; Chen, Nan; London, Wendy B; Krush, Morgan; Anderson, Megan; Gebhardt, Mark; Church, Alanna J; DuBois, Steven G; Pikman, Yana; Spidle, Jennifer; Wall, Catherine B; Feraco, Angela; Ullrich, Nicole J; Mack, Jennifer W; Mullen, Elizabeth; Kamihara, Junne; Forrest, Suzanne; Shusterman, Suzanne; Janeway, Katherine A; Alomari, Ahmad; Padua, Horacio; Rodriguez-Galindo, Carlos; O'Neill, Allison F.
Afiliação
  • Shaikh R; Department of Radiology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Weil BR; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Weldon CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Chen N; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • London WB; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Krush M; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Anderson M; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Gebhardt M; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Church AJ; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • DuBois SG; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Pikman Y; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Spidle J; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Feraco A; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Ullrich NJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Mullen E; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Kamihara J; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Forrest S; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Shusterman S; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Alomari A; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Padua H; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Rodriguez-Galindo C; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
  • O'Neill AF; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Cancer Med ; 12(12): 13300-13308, 2023 06.
Article em En | MEDLINE | ID: mdl-37264747
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article